Clinical outcomes of inferior vena cava filter in complicated pulmonary embolism

Gul, Muhammad; Htun, Zin Mar; Rigdon, Joseph; Rivera‐Lebron, Belinda; Perez, Vinicio de Jesus

doi:10.1177/2045894019882636

Cited by 4 publications

(3 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with and without IVC filter placement with complicated PE were 1:1 propensity score matched for demographics, DVT, Elixhauser Comorbidity Index and other PE comorbidities. Their study found that IVC filter placement reduced mortality rates overall and in each subgroup, corroborating Stein et al’s findings that IVC filters may provide greater benefit in gravely ill patients [ 50 ].…”

Section: Reviewsupporting

confidence: 72%

Inferior Vena Cava Filters and Complications: A Systematic Review

Bajda,

Park,

Raj

et al. 2023

Cureus

View full text Add to dashboard Cite

Inferior vena cava (IVC) filters have been used since the 1960s to treat patients with acute risk of pulmonary embolism (PE) to prevent migration of thrombus by trapping it within the filter. Traditional usage has been in patients with contraindication to anticoagulation that carry a significant mortality risk. In this systematic review, we sought to evaluate complications associated with placement of inferior vena cava filters based on published data from the past 20 years. A search was performed on October 6th, 2022, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews, using three databases (ProQuest, PubMed and ScienceDirect) for articles published between the dates of February 1, 2002 and October 1, 2022. Results were filtered to include full-text, clinical studies, and randomized trials written in English pertaining to keywords “IVC filter AND complications”, “Inferior Vena Cava Filter AND complications”, “IVC filter AND thrombosis” and “Inferior Vena Cava Filter AND thrombosis”. Articles identified by the three databases were pooled and further screened for relevance based on inclusion and exclusion criteria. Initial search results yielded 33,265 hits from all three databases combined. Screening criteria were applied, with 7721 results remaining. After further manual screening, including removal of duplicate hits, a total of 117 articles were selected for review. While there are no consensus guidelines for best practice, there is compelling evidence that IVC filters can provide significant protection against PE with minimal complications if the treatment window is appropriate. Increase in the variety of filter models has led to broader availability, but skepticism remains about their efficacy and safety, with ongoing controversy surrounding appropriate indications. Further research is needed to establish clear guidelines on appropriate indications for IVC placement and to determine time course of complications versus benefits for indwelling filters.

show abstract

Section: Reviewsupporting

confidence: 72%

Inferior Vena Cava Filters and Complications: A Systematic Review

Bajda,

Park,

Raj

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…If DVT exists before surgery, anticoagulation therapy might be ineffective or contraindicated or the proximal DVT, then IVCF insertion can be considered [15]. IVCF has been proven effective in preventing DVT and PE, as well as improving prognosis [17,18]. Nevertheless, lter penetration and fracture as well as the risk of DVT after IVCF insertion has raised concern [18,19].…”

Section: Discussionmentioning

confidence: 99%

Iliac vein thrombectomy in a metastatic ovarian cancer patient: a case report and literature review

Yang¹,

Liu²,

Ning³

et al. 2020

Preprint

View full text Add to dashboard Cite

BackgroundCirculating tumor cells (CTCs) is a major prognostic factor in both primary and metastatic tumor and associated with thrombosis,which may resulted in the formation of Venous thromboembolism (VTE) and the incidence of some adverse events. For the VTE, we can use anticoagulant treatment and Inferior vena cava filter (IVCF) to reduce the risk of pulmonary embolism (PE). However, For large vessels thrombus, These methods can’t solve the problem. So, innovative therapies can quickly and effectively alleviate symptoms and remove tumor thrombus, reducing the possibility of tumor hematogenous dissemination. External iliac venous thrombosis from metastatic ovarian cancer has rarely been reported, especially involving the mechanism that CTCs may lead to the formation of VTE. And little has been reported about the therapy of iliac vein thrombectomy to remove embolus. Here, we present a case of external iliac venous thrombosis and review relevant literature to provide a better recognition of this disease and relevant mechanism.Case presentationThe present case report describes a 60-year-old woman with the external iliac vein thrombosis. She received anticoagulant treatment and we inserted an IVCF to reduce the risk of PE. But it can’t alleviate symptoms and remove tumor thrombus. Finally, we incised external iliac vein to remove the embolus by open operation with the help of multiple disciplinary teamwork(MDT). The IVCF was retrieved on postoperative day nine. And the patient was discharged home on postoperative day twelve. She has good recovery after operation and has no recurrence. ConclusionsThe current report demonstrated that Preoperative IVCF insertion and iliac vein thrombectomy combined with MDT in the treatment of this metastatic cancer patient with deep venous thrombosis(DVT) is effective. And CTCs may involve in the formation of DVT of cancer patients, Exploring the mechanism of VTE that is associated with CTCs is vital important. In addition, Using innovative therapies such as iliac vein thrombectomy to remove embolus is also significant.

show abstract

“…Rather than a procedural complication, this in-hospital mortality rate reflects the clinical severity of presentation of the patients who received the IVC filters. Unfortunately, we do not have access to patients' demographics and comorbidities, which are known to strongly affect mortality in these cases, such as age, presence of pulmonary embolism associated with acute respiratory syndrome or shock (24), advanced stage cancer (25,26) and severe trauma (27), which is a limitation of our study. Nonetheless, the stable distribution of deaths following IVC filter placement over the years, observed in all regions, indicate that even though more IVC filters are being placed recently, the profile of the patients who are receiving them remains similar in terms of severity.…”

Section: Mortality Datamentioning

confidence: 99%

Epidemiology of the use of inferior vena cava filters in Brazil between 2008 and 2019

Louzada

Leiderman

Silva

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: to study the totality of inferior vena cava filters placed in the Brazilian Public Health System, which insures more than 160 million Brazilians, trends by geographic region and in-hospital deaths after filter placements and also due to pulmonary embolism between 2008 and 2019. Patients and methods: public and open data regarding in-hospital mortality due to pulmonary embolism and all inferior vena cava filters placed in Brazilian public hospitals between January 2008 and December 2019 were extracted from the Brazilian Public Health System databases. Results: 9108 inferior vena cava filters were placed, 98.18% of which was therapeutic. There was an overall increasing use of these devices, statistically significant for all Brazilian regions, except the North. In-hospital mortality rate in patients who received inferior vena cava filters was 6.21%, stable over time. We observed an upward trend in in-hospital mortality rate due to pulmonary embolism, statistically significant for all Brazilian regions, except the North. Conclusion: We observed a low standardized rate of inferior vena cava filter placements in Brazil between 2008 and 2019, but with a trend towards an increasing trend use. Almost all indications for filter placement were therapeutic. In hospital mortality in patients receiving inferior vena cava filters was high, 6.21%, and stable over time, whereas the trend of in-hospital mortality rate due to pulmonary embolism is increasing. Our findings were heterogeneous across Brazilian regions and contrasted to those observed in the USA, which is likely due to cultural and socioeconomic factors.

show abstract

Clinical outcomes of inferior vena cava filter in complicated pulmonary embolism

Cited by 4 publications

References 44 publications

Inferior Vena Cava Filters and Complications: A Systematic Review

Inferior Vena Cava Filters and Complications: A Systematic Review

Iliac vein thrombectomy in a metastatic ovarian cancer patient: a case report and literature review

Epidemiology of the use of inferior vena cava filters in Brazil between 2008 and 2019

Contact Info

Product

Resources

About